NRC Health Current Assets
NRC Health (NRC) had Current Assets of $22.81 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-04
- 2026-06-30: Assets, Current $22.81M.
- 2026-03-31: Assets, Current $19.98M.
- 2025-12-31: Assets, Current $20.21M.
- 2025-09-30: Assets, Current $20.40M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $22.81M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $19.98M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $20.21M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $20.40M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $25.32M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $20.40M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $19.60M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $20.70M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $16.95M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $20.01M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $24.36M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $24.74M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $40.99M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $45.17M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $43.72M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $49.10M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $51.78M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $68.92M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $73.71M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $72.73M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $67.59M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $62.23M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $54.11M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $47.37M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $36.70M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $34.94M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $29.16M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $26.57M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $22.89M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $22.87M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $28.41M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $28.77M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $23.63M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $52.28M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $52.26M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $53.82M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $50.98M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $52.38M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $47.06M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $45.92M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $42.74M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $44.81M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $55.06M 10-K · filed 2017-03-03 | $56.11M 10-K · filed 2016-03-04 |
| 2015-09-30 | $56.07M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $55.77M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $53.17M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $53.19M 10-K · filed 2016-03-04 | |
| 2014-09-30 | $53.20M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $47.48M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $42.27M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $36.57M 10-K · filed 2015-03-04 | $36.47M 10-K · filed 2014-03-04 |
| 2013-09-30 | $34.91M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $29.66M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $27.87M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $23.82M 10-K · filed 2014-03-04 | |
| 2012-09-30 | $32.45M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $28.22M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $25.26M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $22.14M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $21.63M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $20.84M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $17.34M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |